Q3 2025 Holdings
Filed 2025-11-14 | 18 holdings | $435.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Johnson & Johnson(JNJ) | COM | 478160104 | $56.2M | 302,831 | 12.9% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $51.2M | 122,187 | 11.8% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $37.5M | 446,874 | 8.6% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $35.5M | 292,137 | 8.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $34.8M | 174,829 | 8.0% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $34.6M | 1,190,207 | 8.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $32.0M | 43,411 | 7.4% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $31.1M | 67,706 | 7.1% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $30.5M | 450,585 | 7.0% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $20.8M | 89,621 | 4.8% |
| Korro BIO Inc(KRRO) | COM | 500946108 | $16.2M | 337,764 | 3.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $14.7M | 366,102 | 3.4% |
| Avadel Pharmaceuticals PLC | COM SHS | G29687103 | $11.1M | 724,859 | 2.5% |
| Stevanato Group S P A(STVN) | ORD SHS | T9224W109 | $8.6M | 332,912 | 2.0% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $7.2M | 182,867 | 1.7% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $7.1M | 119,260 | 1.6% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $4.0M | 75,986 | 0.9% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $2.2M | 149,179 | 0.5% |